Oct. 24 at 2:11 AM
What the what....
Preliminary research being reported in the journal Nature: People w/ advanced lung or skin cancer who were taking certain immunotherapy drugs lived substantially longer if they also got a
$PFE or
$MRNA shot within 100 days of starting treatment
Vaccinated lung cancer patients were nearly twice as likely to be alive 3 years after beginning cancer treatment as the unvaccinated patients.
The molecule that powers those specific vaccines, mRNA, appears to help the immune system respond better to the cutting-edge cancer treatment, concluded researchers
Lead researcher: The vaccine “acts like a siren to activate immune cells throughout the body. We’re sensitizing immune-resistant tumors to immune therapy.”
The research team found its results so promising that it is preparing a more rigorous study to see if mRNA coronavirus vaccines should be paired w/ cancer drugs called checkpoint inhibitors — an interim step while it designs new mRNA vaccines for use in cancer.
